Common Contracts
5 similar null contracts by Altitude International Holdings, Inc., Eastside Distilling, Inc., NV5 Holdings, Inc., others
Unaudited Pro Forma Condensed Consolidated Financial InformationQualigen Therapeutics, Inc. • July 26th, 2023 • Pharmaceutical preparations
On July 20, 2023 (the “Closing Date”), Qualigen Therapeutics, Inc., a Delaware corporation (the “Company”), entered into a stock purchase agreement (the “Purchase Agreement”) with Chembio Diagnostics, Inc. (the “Buyer”), Biosynex, S.A. (“Biosynex”), and Qualigen, Inc., a wholly-owned subsidiary of the Company (the “Subsidiary”). Pursuant to the Purchase Agreement, the Company agreed to sell to the Buyer all of the issued and outstanding shares of common stock (collectively, the “Shares”) of the Subsidiary, which was the legal entity operating the Company’s FastPack™ diagnostics business (the “Transaction”). The Transaction closed on July 20, 2023. Following the consummation of the Transaction, the Subsidiary became a wholly-owned subsidiary of the Buyer.
ALTITUDE INTERNATIONAL HOLDINGS, INC. UNAUDITED PRO-FORMA CONDENSED COMBINED FINANCIAL INFORMATIONAltitude International Holdings, Inc. • May 19th, 2022 • Services-help supply services
On March 7, 2022, Altitude International Holdings, Inc. (the “Company”) and its wholly owned subsidiary CMA Soccer, LLC (“CMAS”), entered into a Consulting, Management and License Agreement (the “Agreement”) with Soccer Partners America, a Colorado not-for-profit corporation (“RUSH Soccer”).
TTM Digital Assets & Technologies, Inc. and Subsidiaries UNAUDITED COMBINED CONDENSED PRO FORMA FINANCIAL INFORMATIONSysorex, Inc. • June 24th, 2021 • Services-computer programming services
On April 8, 2021, Sysorex, Inc. (“Sysorex”), TTM Digital Assets & Technologies, Inc. (“TTM Digital” or the “Company”), and TTM Acquisition Corp., a Nevada corporation, a wholly owned subsidiary of Sysorex (“MergerSub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”). Under the terms of the Merger Agreement, the parties agreed that at the Effective Time (defined below), Sysorex would acquire the Company by way of a reverse triangular merger, subject to certain closing conditions (the “Merger”). On April 14, 2021 (the “Effective Time”), the closing conditions delineated in the Merger Agreement were satisfied and the Merger closed. At the Effective Time, the MergerSub was merged with and into TTM Digital with TTM Digital surviving the Merger. Under the terms of the Merger Agreement, the Shareholders of TTM Digital received a right to receive an aggregate of 124,218,268 shares of Sysorex common stock, $0.00001 par value per share (the “Merger Shares”) in exchange for
Eastside Distilling, Inc. and Subsidiaries Unaudited Pro Forma Combined Financial InformationEastside Distilling, Inc. • November 13th, 2019 • Beverages
On September 12, 2019, Eastside Distilling, Inc., a Nevada corporation (“Eastside”), and Intersect Beverage, LLC, a California limited liability company (“Intersect”), entered into an Asset Purchase Agreement (the “Agreement”). In accordance with the terms and subject to the conditions set forth in the Agreement, Eastside agreed to purchase substantially all of the assets of Intersect (the “Purchased Assets”), an importer and distributor of tequila and related products (the “Transaction”) under the brand name “Azuñia”. The following unaudited pro forma combined financial statements are based the historical consolidated financial statements of Eastside and adjusts such information to give effect of the Agreement.
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL DATANV5 Holdings, Inc. • April 14th, 2015 • Services-miscellaneous business services
On January 30, 2015, NV5 Holdings, Inc., a Delaware corporation (the “Company”), entered into a Stock Purchase Agreement (the “Agreement”) with Joslin, Lesser & Associates, Inc. (“JLA”), a Massachusetts corporation, each of the holders of issued and outstanding shares of JLA (“the Sellers”), and Stuart D. Lesser, solely in his capacity as the stockholder representative, to acquire all of the outstanding equity interests in JLA for an aggregate purchase price consideration of up to $5.5 million, subject to adjustments in accordance with the terms of the Agreement.
